The trademark application CAPSUVENT was filed by Glenmark Pharmaceuticals s.r.o., a corporation established under the laws of the Czech Republic (the "Applicant"). The application was published for oppositions on May 25, 2021, and it was registered by office on September 1, 2021 without any oppositions.
The application was filed in English (Spanish was selected as the second language).